BioNTech und CEPI geben Partnerschaft zur Entwicklung eines mRNA-Mpox-Impfstoffs und zur Unterstützung von CEPIs 100-Tage-Ziel bekannt
September 18, 2023 06:45 ET
|
BioNTech SE
BioNTech bereitet klinische Phase-1/2-Studie für das mRNA-basierte Mpox-Impfstoffprogramm BNT166 vorDie Coalition for Epidemic Preparedness Innovations (CEPI) stellt bis zu 90 Millionen US-Dollar für...
Dyadic to Present at BioProcess International
September 12, 2023 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Global Clinical Laboratory Services Market Size to Reach USD 300.23 Billion in 2032 | Emergen Research
August 28, 2023 11:30 ET
|
Emergen Research
Vancouver, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Anticipated to attain a value of USD 300.23 Billion by 2032, the global clinical laboratory services market is poised for steady advancement with a...
OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023 16:15 ET
|
OpGen, Inc.
Total revenue for the first half of 2023 was approximately $1.65 million, an increase of approximately 15% compared to approximately $1.44 million in the first half of 2022Signed FIND R&D...
OpGen to Provide Business Update and Financial Results for the Second Quarter 2023 on August 10th at 4:30 p.m. Eastern Time
August 03, 2023 07:30 ET
|
OpGen, Inc.
ROCKVILLE, Md., Aug. 03, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its second quarter...
OpGen’s Subsidiary Curetis Meets Milestones of Extended and Expanded R&D Collaboration with FIND
July 19, 2023 07:30 ET
|
OpGen, Inc.
All milestones successfully met, including antibiotic stewardship module, mobile and cloud-based data access as well as comprehensive next generation sequencing resultsTriggers additional milestone...
60 Degrees Pharmaceuticals Announces Closing of Initial Public Offering
July 14, 2023 12:39 ET
|
Sixty Degrees Pharmaceuticals
WASHINGTON, July 14, 2023 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc., (NASDAQ: SXTP; SXTPW) (“60P” or the “Company”), specialists in developing and marketing medicines for infectious...
Infectious Disease Diagnostics Market Size is Expanding to USD 56.62 Billion by 2032
July 10, 2023 10:00 ET
|
Precedence Research
Ottawa, July 10, 2023 (GLOBE NEWSWIRE) -- According to Precedence Research, the global infectious disease diagnostics market size was valued at USD 28.65 billion in 2022. Infectious disease...
In Silico Clinical Trials Market to Surpass US$ 5,824.6 Million by 2030, Says Coherent Market Insights (CMI)
June 28, 2023 11:31 ET
|
CMI
Burlingame, June 28, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global In Silico Clinical Trials Market is estimated to be valued at US$ 3,410.4 million in 2023 and is...
ExeVir Bio Awarded EUR 1.6m Grant for Dengue Research
June 28, 2023 03:09 ET
|
ExeVir Bio
Dengue is a mosquito-borne viral infection listed by WHO as top 10 threat for global health The government grant is awarded by Flanders Innovation & Entrepreneurship (VLAIO) GHENT, Belgium, June...